Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Braz J Med Biol Res ; 39(11): 1435-44, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17146556

ABSTRACT

Evidence based on immunological cross-reactivity and anti-diabetic properties has suggested the presence of insulin-like peptides in plants. The objective of the present study was to investigate the presence of insulin-like proteins in the leaves of Bauhinia variegata ("pata-de-vaca", "mororó"), a plant widely utilized in popular medicine as an anti-diabetic agent. We show that an insulin-like protein was present in the leaves of this plant. A chloroplast protein with a molecular mass similar to that of bovine insulin was extracted from 2-mm thick 15% SDS-PAGE gels and fractionated with a 2 x 24 cm Sephadex G-50 column. The activity of this insulin-like protein (0.48 mg/mL) on serum glucose levels of four-week-old Swiss albino (CF1) diabetic mice was similar to that of commercial swine insulin used as control. Further characterization of this molecule by reverse-phase hydrophobic HPLC chromatographic analysis as well as its antidiabetic activity on alloxan-induced mice showed that it has insulin-like properties. Immunolocalization of the insulin-like protein in the leaves of B. variegata was performed by transmission electron microscopy using a polyclonal anti-insulin human antibody. Localization in the leaf blades revealed that the insulin-like protein is present mainly in chloroplasts where it is also found associated with crystals which may be calcium oxalate. The presence of an insulin-like protein in chloroplasts may indicate its involvement in carbohydrate metabolism. This finding has strengthened our previous results and suggests that insulin-signaling pathways have been conserved through evolution.


Subject(s)
Bauhinia/chemistry , Chloroplasts/chemistry , Diabetes Mellitus, Experimental/drug therapy , Hypoglycemic Agents/isolation & purification , Insulin-Like Growth Factor Binding Proteins/isolation & purification , Plant Leaves/chemistry , Animals , Autoantibodies/blood , Bauhinia/cytology , Cattle , Chloroplasts/ultrastructure , Chromatography, High Pressure Liquid , Electrophoresis, Polyacrylamide Gel , Hypoglycemic Agents/therapeutic use , Immunoglobulin G/blood , Insulin-Like Growth Factor Binding Proteins/therapeutic use , Mice , Microscopy, Electron, Transmission , Plant Leaves/cytology
2.
Braz. j. med. biol. res ; 39(11): 1435-1444, Nov. 2006. ilus, graf
Article in English | LILACS | ID: lil-437826

ABSTRACT

Evidence based on immunological cross-reactivity and anti-diabetic properties has suggested the presence of insulin-like peptides in plants. The objective of the present study was to investigate the presence of insulin-like proteins in the leaves of Bauhinia variegata ("pata-de-vaca", "mororó"), a plant widely utilized in popular medicine as an anti-diabetic agent. We show that an insulin-like protein was present in the leaves of this plant. A chloroplast protein with a molecular mass similar to that of bovine insulin was extracted from 2-mm thick 15 percent SDS-PAGE gels and fractionated with a 2 x 24 cm Sephadex G-50 column. The activity of this insulin-like protein (0.48 mg/mL) on serum glucose levels of four-week-old Swiss albino (CF1) diabetic mice was similar to that of commercial swine insulin used as control. Further characterization of this molecule by reverse-phase hydrophobic HPLC chromatographic analysis as well as its antidiabetic activity on alloxan-induced mice showed that it has insulin-like properties. Immunolocalization of the insulin-like protein in the leaves of B. variegata was performed by transmission electron microscopy using a polyclonal anti-insulin human antibody. Localization in the leaf blades revealed that the insulin-like protein is present mainly in chloroplasts where it is also found associated with crystals which may be calcium oxalate. The presence of an insulin-like protein in chloroplasts may indicate its involvement in carbohydrate metabolism. This finding has strengthened our previous results and suggests that insulin-signaling pathways have been conserved through evolution.


Subject(s)
Animals , Cattle , Mice , Bauhinia/chemistry , Chloroplasts/chemistry , Diabetes Mellitus, Experimental/drug therapy , Hypoglycemic Agents/isolation & purification , Insulin-Like Growth Factor Binding Proteins/isolation & purification , Plant Leaves/chemistry , Autoantibodies/blood , Bauhinia/cytology , Chromatography, High Pressure Liquid , Chloroplasts/ultrastructure , Electrophoresis, Polyacrylamide Gel , Hypoglycemic Agents/therapeutic use , Immunoglobulin G/blood , Insulin-Like Growth Factor Binding Proteins/therapeutic use , Microscopy, Electron, Transmission , Plant Leaves/cytology
4.
Inflamm Res ; 46(2): 72-7, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9085147

ABSTRACT

OBJECTIVE: To assess involvement of nitric oxide (NO) in the increase in eicosanoid and interleukin- 1 (IL-1) levels in the synovial fluid during antigen-induced arthritis (AIA) in rabbits treated with a competitive inhibitor of NO synthesis. SUBJECTS: Thirteen New Zealand White rabbits were sensitized with 5 mg of methylated bovine serum albumin (mBSA). Arthritis was induced in the knee joint by injecting 0.5 ml of a sterile solution of mBSA (2 mg/ml) into the intra-articular cavity. TREATMENT: Prior to the induction of arthritis, the animals received N-Omega-Nitro-L-Arginine Methyl Ester (LNAME) or N-Omega-Nitro-D-Arginine Methyl Ester (DNAME) for 2 weeks, both at a dose of 20 mg/kg/day mixed with drinking water. METHODS: Leukocyte efflux (total and differential white cell count), vascular permeability (Evans's blue method), synovial PMN cell infiltrate, and total nitrite (NO2.)/nitrate (NO3.) (HPLC), PGE2, TxB2, LTB4 (radioimmunoassay), and IL-1 beta (ELISA) levels were quantified in the synovial fluid. RESULTS: LNAME but not DNAME significantly suppressed leukocyte efflux and protein leakage into the articular cavity as well as synovial PMN cell infiltrate. Total NO2./NO3., PGE2 and IL-1 beta levels were significantly reduced in the synovial fluid of LNAME treated animals. TxB2 and LTB4 were not affected by LNAME treatment. CONCLUSION: These data clearly show NO involvement in the IL-1-induced PGE2 production in the synovial fluid of antigen-induced arthritis in rabbits.


Subject(s)
Arthritis, Experimental/drug therapy , Dinoprostone/biosynthesis , Interleukin-1/biosynthesis , Knee Joint/drug effects , Nitric Oxide Synthase/antagonists & inhibitors , Animals , Arthritis, Experimental/metabolism , Arthritis, Experimental/pathology , Capillary Permeability/drug effects , Capillary Permeability/immunology , Chemotaxis, Leukocyte/drug effects , Chemotaxis, Leukocyte/immunology , Dinoprostone/adverse effects , Dinoprostone/chemistry , Dinoprostone/metabolism , Disease Models, Animal , Eicosanoids/chemistry , Interleukin-1/chemistry , Interleukin-1/metabolism , Knee Joint/pathology , Male , Nitrates/analysis , Nitric Oxide/adverse effects , Nitric Oxide/chemistry , Nitric Oxide/metabolism , Nitric Oxide Synthase/adverse effects , Nitric Oxide Synthase/metabolism , Nitrites/analysis , Rabbits , Synovial Fluid/chemistry , Synovial Membrane/pathology
5.
J Rheumatol ; 24(12): 2429-35, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9415654

ABSTRACT

OBJECTIVE: Parathyroid hormone (PTH) induced bone resorption by osteoclasts depends on the presence of osteoblasts. PTH induced production of prostaglandins by osteoblasts and induction of bone resorption by prostaglandins suggest that these autacoids may be implicated in the effects of PTH on bone. Our objective was to determine if the increase in prostaglandin production induced in human osteoblasts by PTH is due to an increase in cyclooxygenase-2 (COX-2) expression. METHODS: Primary cultures of human osteoblasts were obtained from specimens of trabecular bone. Confluent cells were treated with PTH, dexamethasone or compound NS-398, a specific COX-2 inhibitor. The concentration of prostaglandin E2 (PGE2) in the supernatants was determined by radioimmunoassay and COX-2 mRNA levels evaluated by Northern blot. RESULTS: PTH induced COX-2 mRNA expression and PGE2 production. These effects were time and concentration dependent and were inhibited by dexamethasone. Compound NS-398 reduced PGE2 production to the same extent as dexamethasone, and neither compound had an additive effect on this variable. CONCLUSION: These results show that PTH induces COX-2 expression in human osteoblasts in culture and suggest that this isoenzyme is the main factor in the control of prostaglandin synthesis in these experimental conditions.


Subject(s)
Isoenzymes/genetics , Osteoblasts/drug effects , Osteoblasts/enzymology , Parathyroid Hormone/pharmacology , Prostaglandin-Endoperoxide Synthases/genetics , Cells, Cultured , Cyclooxygenase 1 , Cyclooxygenase 2 , Cyclooxygenase 2 Inhibitors , Cyclooxygenase Inhibitors/pharmacology , Dinoprostone/metabolism , Gene Expression Regulation/drug effects , Humans , Interleukin-1/pharmacology , Membrane Proteins , Nitrobenzenes/pharmacology , Osteoblasts/cytology , RNA, Messenger/metabolism , Sulfonamides/pharmacology , Tumor Necrosis Factor-alpha/pharmacology
6.
Surg Gynecol Obstet ; 177(4): 383-8, 1993 Oct.
Article in English | MEDLINE | ID: mdl-8211583

ABSTRACT

In a effect to prevent nosocomial pneumonia and sepsis, we treated patients with severe multiple trauma with an immunomodulator--beta 1-3 polyglucose (glucan). Forty-one patients with no infection at admission were stratified using Trauma Score and included in a randomized double-blind controlled trial. They were divided into a control group (n = 20) and a glucan group (n = 21). Pneumonia occurred in 11 of 20 patients in the control group and in two of 21 recipients of glucan (p < 0.01). Sepsis occurred in seven of 20 patients in the control group and in two of 21 patients treated with glucan (p < 0.05). Considering patients with pneumonia and sepsis, a decrease was observed in nosocomial infection from 65.0 to 14.4 percent (p < 0.001). The mortality rate related to infection was 30.0 percent in patients in the control group and 4.8 percent in the group treated with glucan (p < 0.05). The general mortality rate, cerebral deaths excluded, was 42.1 percent in the control group and 23.5 percent in the glucan group.


Subject(s)
Adjuvants, Immunologic/therapeutic use , Bacterial Infections/prevention & control , Craniocerebral Trauma/complications , Cross Infection/prevention & control , Glucans/therapeutic use , Multiple Trauma/complications , Pneumonia/prevention & control , beta-Glucans , Adult , Bacterial Infections/mortality , Craniocerebral Trauma/mortality , Cross Infection/mortality , Double-Blind Method , Female , Humans , Incidence , Male , Multiple Trauma/mortality , Pneumonia/mortality
7.
Arq Bras Cardiol ; 59(2): 95-8, 1992 Aug.
Article in Portuguese | MEDLINE | ID: mdl-1341165

ABSTRACT

PURPOSE: To evaluate cardiac alterations secondary to exogenous intoxication by paraquat. METHODS: We performed analysis of clinical and laboratory data of 25 patients with acute paraquat poisoning admitted in our ICU from November 1983 to January 1991. RESULTS: There were purposeful overdoses in 24 cases (96%). The mortality rate was 56%. The lung involvement was 96%, renal was 92%, gastrointestinal tract was 72%, hepatic was 56%, and cardiac involvement was 40%. CONCLUSION: Cardiac involvement due to paraquat is frequent (40%). The clinical picture of this involvement has a wide spectrum, ranging from minimal changes in the ECG to acute and extensive myocardial necrosis.


Subject(s)
Heart Diseases/chemically induced , Paraquat/poisoning , Adolescent , Adult , Brazil/epidemiology , Electrocardiography/drug effects , Female , Heart Diseases/diagnosis , Heart Diseases/mortality , Humans , Male , Middle Aged , Poisoning/diagnosis , Poisoning/mortality , Suicide, Attempted/statistics & numerical data
SELECTION OF CITATIONS
SEARCH DETAIL
...